HKD 7.71
(0.13%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 151.71 Million CNY | 72.99% |
2022 | 87.7 Million CNY | 12.89% |
2021 | 77.68 Million CNY | -71.97% |
2020 | 277.17 Million CNY | 4.03% |
2019 | 266.44 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 169.42 Million CNY | 0.0% |
2024 Q1 | 169.42 Million CNY | 11.68% |
2023 Q4 | 151.71 Million CNY | 0.0% |
2023 FY | 151.71 Million CNY | 72.99% |
2023 Q1 | 78.42 Million CNY | -10.57% |
2023 Q3 | 151.71 Million CNY | 93.44% |
2023 Q2 | 78.42 Million CNY | 0.0% |
2022 Q3 | 87.7 Million CNY | -11.31% |
2022 Q1 | 98.88 Million CNY | 27.29% |
2022 FY | 87.7 Million CNY | 12.89% |
2022 Q4 | 87.7 Million CNY | 0.0% |
2022 Q2 | 98.88 Million CNY | 0.0% |
2021 Q3 | 77.68 Million CNY | 0.0% |
2021 Q4 | 77.68 Million CNY | 0.0% |
2021 Q1 | - CNY | 0.0% |
2021 FY | 77.68 Million CNY | -71.97% |
2020 FY | 277.17 Million CNY | 4.03% |
2019 FY | 266.44 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Life Healthcare Group Limited | 70.08 Million HKD | -116.473% |
China Biotech Services Holdings Limited | 171.63 Million HKD | 11.607% |